BNT162B2 COVID-19 mRNA vaccination did not promote substantial anti-syncytin-1 antibody production nor mRNA transfer to breast milk in an exploratory pilot study

Ann Acad Med Singap. 2022 May;51(5):309-312. doi: 10.47102/annals-acadmedsg.2021447.

Authors

Citra N Z Mattar¹, Winston Koh, Yiqi Seow, Shawn Hoon, Aparna Venkatesh, Pradip Dashraath, Li Min Lim, Judith Ong, Rachel Lee, Nuryanti Johana, Julie S L Yeo, David Chong, Lay Kok Tan, Jerry K Y Chan, Mahesh Choolani, Paul Anantharajah Tambyah

Affiliation

¹ Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

PMID: 35658155
DOI: 10.47102/annals-acadmedsg.2021447

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Viral
Antibody Formation
BNT162 Vaccine
COVID-19* / prevention & control
Female
Humans
Milk, Human*
Pilot Projects
RNA, Messenger
Vaccination

Substances

Antibodies, Viral
RNA, Messenger
BNT162 Vaccine